Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 13, 2021
Total Value: $279M (97.3% shares, 2.7% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BRIDGEBIO PHARMA INC | 550,000 | $33.53M | 12.0% | $60.81 | -6.1% | COM | 10806X102 |
| XBI | SPDR SER TR | 200,000 | $27.08M | 9.7% | — | — | Put | 78464A870 |
| ARKG | ARK ETF TR | 225,000 | $20.81M | 7.5% | — | — | Put | 00214Q302 |
| — | MORPHIC HLDG INC | 246,201 | $14.13M | 5.1% | $53.91 | — | COM | 61775R105 |
| — | CUREVAC N V | 150,000 | $11.02M | 3.9% | — | — | Put | N2451R105 |
| — | VINCERX PHARMA INC | 838,311 | $10.89M | 3.9% | $17.85 | — | COM NEW | 92731L106 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 900,000 | $9.09M | 3.3% | $10.83 | 0.0% | COM | 63909J108 |
| KURA | KURA ONCOLOGY INC | 425,000 | $8.861M | 3.2% | $32.82 | -24.4% | COM | 50127T109 |
| — | INARI MED INC | 85,000 | $7.929M | 2.8% | $99.03 | — | COM | 45332Y109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 142,418 | $7.577M | 2.7% | $47.84 | +11.9% | COM | 98943L107 |
| — | ARYA SCIENCES ACQU CORP IV | 700,000 | $7.504M | 2.7% | $10.47 | — | CL A | G31659108 |
| — | ACCELERON PHARMA INC | 55,000 | $6.902M | 2.5% | $127.49 | — | COM | 00434H108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 140,100 | $6.288M | 2.3% | $30.26 | +9.1% | COM | 74366E102 |
| — | RETROPHIN INC | 7,000,000 | $5.993M | 2.1% | $0.94 | — | NOTE 2.500% 9/1 | 761299AB2 |
| RCKT | ROCKET PHARMACEUTICALS INC | 120,000 | $5.315M | 1.9% | $38.49 | +12.8% | COM | 77313F106 |
| — | CURIS INC | 650,000 | $5.246M | 1.9% | $8.19 | — | COM NEW | 231269200 |
| — | CEREVEL THERAPEUTICS HLDNG I | 200,000 | $5.124M | 1.8% | $16.58 | — | COM | 15678U128 |
| ACRS | ACLARIS THERAPEUTICS INC | 275,000 | $4.829M | 1.7% | $20.16 | +12.7% | COM | 00461U105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 25,000 | $4.238M | 1.5% | — | — | Call | 02043Q107 |
| OCUL | OCULAR THERAPEUTIX INC | 250,000 | $3.545M | 1.3% | $15.01 | +1.2% | COM | 67576A100 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.06M | 1.1% | $12.02 | — | ORD SHS | G4411D109 |
| IONS | IONIS PHARMACEUTICALS INC | 75,000 | $2.992M | 1.1% | — | — | Call | 462222100 |
| MRNA | MODERNA INC | 12,500 | $2.937M | 1.1% | — | — | Call | 60770K107 |
| — | MEDICUS SCIENCES ACQUISITION | 300,000 | $2.895M | 1.0% | $9.65 | — | CL A SHS | G5960S108 |
| — | CHINOOK THERAPEUTICS INC | 200,000 | $2.824M | 1.0% | $15.60 | — | COM | 16961L106 |
| LUNG | PULMONX CORP | 60,000 | $2.647M | 0.9% | $51.11 | -14.8% | COM | 745848101 |
| ASND | ASCENDIS PHARMA A/S | 20,000 | $2.631M | 0.9% | $147.85 | — | SPONSORED ADR | 04351P101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 100,000 | $2.602M | 0.9% | $29.45 | -11.7% | COM | 462260100 |
| — | HORIZON THERAPEUTICS PUB L | 25,000 | $2.341M | 0.8% | $73.16 | — | SHS | G46188101 |
| ALDX | ALDEYRA THERAPEUTICS INC | 200,000 | $2.266M | 0.8% | $10.02 | +20.0% | COM | 01438T106 |
| — | CYCLACEL PHARMACEUTICALS INC | 380,000 | $2.25M | 0.8% | $7.33 | — | COM | 23254L603 |
| MGNX | MACROGENICS INC | 80,000 | $2.149M | 0.8% | $27.72 | +5.6% | COM | 556099109 |
| MREO | MEREO BIOPHARMA GROUP PLC | 650,000 | $2.061M | 0.7% | $3.52 | — | ADS | 589492107 |
| — | SPRINGWORKS THERAPEUTICS INC | 25,000 | $2.06M | 0.7% | $73.56 | — | COM | 85205L107 |
| — | ESSA PHARMA INC | 70,000 | $2M | 0.7% | $29.06 | — | COM NEW | 29668H708 |
| SDGR | SCHRODINGER INC | 25,000 | $1.89M | 0.7% | $72.49 | 0.0% | COM | 80810D103 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 20,000 | $1.747M | 0.6% | $66.04 | +12.7% | COM | G31249108 |
| AXSM | AXSOME THERAPEUTICS INC | 25,000 | $1.687M | 0.6% | $65.92 | -9.0% | COM | 05464T104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 50,000 | $1.672M | 0.6% | $20.10 | +36.6% | COM NEW | 15117B202 |
| NTLA | INTELLIA THERAPEUTICS INC | 10,000 | $1.619M | 0.6% | $77.87 | 0.0% | COM | 45826J105 |
| — | GOSSAMER BIO INC | 2,000,000 | $1.605M | 0.6% | $0.80 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| — | LIFESCI ACQUISITION II CORP | 150,000 | $1.5M | 0.5% | $10.54 | — | COM | 53229E103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 66,957 | $1.487M | 0.5% | $22.21 | — | SPONSORED ADS | 152309100 |
| BFLY | BUTTERFLY NETWORK INC | 100,000 | $1.448M | 0.5% | $19.79 | -31.8% | COM CL A | 124155102 |
| GLPG | GALAPAGOS NV | 20,000 | $1.387M | 0.5% | $74.21 | — | SPON ADR | 36315X101 |
| CYTK | CYTOKINETICS INC | 70,000 | $1.385M | 0.5% | $20.51 | +14.5% | COM NEW | 23282W605 |
| AFIB | ACUTUS MED INC | 80,000 | $1.358M | 0.5% | $20.54 | -28.8% | COM | 005111109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 50,000 | $1.198M | 0.4% | $22.17 | +18.0% | COM | 483497103 |
| CGEM | CULLINAN ONCOLOGY INC | 45,000 | $1.159M | 0.4% | $30.75 | 0.0% | COM | 230031106 |
| — | MERSANA THERAPEUTICS INC | 85,000 | $1.154M | 0.4% | $22.32 | — | COM | 59045L106 |
| — | BCTG ACQUISITION CORP | 100,000 | $1.138M | 0.4% | $11.44 | — | COM | 05492W103 |
| PCVX | VAXCYTE INC | 50,000 | $1.126M | 0.4% | $30.49 | -32.9% | COM | 92243G108 |
| — | CEREVEL THERAPEUTICS HLDNG I | 72,466 | $1.043M | 0.4% | $5.64 | — | *W EXP 06/09/2020 | 15678U102 |
| — | ZYMEWORKS INC | 30,000 | $1.041M | 0.4% | $44.32 | — | COM | 98985W102 |
| — | NANOSTRING TECHNOLOGIES INC | 15,000 | $972K | 0.3% | $64.80 | — | COM | 63009R109 |
| — | BELLUS HEALTH INC NEW | 300,000 | $933K | 0.3% | $3.84 | — | COM NEW | 07987C204 |
| QSI | QUANTUM SI INC | 75,000 | $920K | 0.3% | $10.48 | 0.0% | COM CL A | 74765K105 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 75,000 | $819K | 0.3% | $10.52 | — | UNIT 99/99/9999 | 15957T206 |
| — | ACHILLES THERAPEUTICS PLC | 80,000 | $783K | 0.3% | $11.90 | — | SPONSORED ADS | 00449L102 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 20,000 | $700K | 0.3% | $43.32 | — | COM | 37890U108 |
| — | HARPOON THERAPEUTICS INC | 50,000 | $694K | 0.2% | $16.69 | — | COM | 41358P106 |
| — | IMMATICS N.V | 190,000 | $654K | 0.2% | $2.88 | — | *W EXP 07/01/2020 | N44445117 |
| — | ITEOS THERAPEUTICS INC | 25,000 | $641K | 0.2% | $25.64 | — | COM | 46565G104 |
| APLS | APELLIS PHARMACEUTICALS INC | 10,000 | $632K | 0.2% | $51.60 | 0.0% | COM | 03753U106 |
| CTMX | CYTOMX THERAPEUTICS INC | 75,000 | $475K | 0.2% | $7.87 | -1.1% | COM | 23284F105 |
| IMVT | IMMUNOVANT INC | 30,000 | $317K | 0.1% | — | — | Call | 45258J102 |
| — | THE BEAUTY HEALTH COMPANY | 45,000 | $288K | 0.1% | $6.40 | — | *W EXP 05/04/2026 | 88331L116 |
| CVRX | CVRX INC | 7,500 | $210K | 0.1% | $28.00 | 0.0% | COM | 126638105 |
| — | MEDICUS SCIENCES ACQUISITION | 33,333 | $34,000 | 0.0% | $1.02 | — | *W EXP 02/12/2026 | G5960S124 |